Leiden Clinical Prediction Rule for Undifferentiated Arthritis

ورودی‌های بالینی بیمار

حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years

حداقل ۰ — حداکثر ۶۸ • واحد: joints

حداقل ۰ — حداکثر ۶۶ • واحد: joints

حداقل ۰ — حداکثر ۵۰۰ • واحد: mg/L

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
leiden prediction score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–6
  • Indeterminate Risk6.01–7.99
  • High Risk8–20
Direct Clinical Answer

The Leiden Clinical Prediction Rule for Undifferentiated Arthritis calculates classifying inflammatory arthritides and monitoring longitudinal autoimmune disease activity. Key inputs include age years. Scores guide initiating or optimizing disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Diagnoses rheumatoid arthritis in patients with recent-onset undifferentiated arthritis by predicting the likelihood of progression from undifferentiated arthritis to rheumatoid arthritis within one year

Clinical Indication

The Leiden Clinical Prediction Rule for Undifferentiated Arthritis is indicated for bedside clinical practice to support Diagnoses rheumatoid arthritis in patients with recent-onset undifferentiated arthritis by predicting the likelihood of progression from undifferentiated arthritis to rheumatoid arthritis within one year. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with inflammatory arthritis, systemic lupus erythematosus, systemic vasculitis, or autoimmune connective tissue disorders. Clinical application is indicated across Rheumatology clinics, connective tissue disease units, and academic medical centers.

Limitations & Contraindications

Elevated erythrocyte sedimentation rate (ESR) and CRP are non-specific acute phase reactants that can reflect occult systemic infection.

Clinical Pearls & Action Plan

Serological autoantibody testing must strictly correlate with inflammatory joint patterns and objective synovial pathology. Guideline pearl: High specificity for identifying patients who will progress to RA.

Formula & Variables:

Score = (Age × 0.02) + Sex points + Joint distribution points + Symmetric distribution points + Morning stiffness points + Tender joints points + Swollen joints points + CRP points + RF points + Anti-CCP points

Input Parameters

NameTypeRequiredDescription
age_yearsintegerYesPatient age in years (multiplied by 0.02 in calculation)(years)
sexstringYesPatient sex
joint_distributionstringYesDistribution pattern of affected joints
symmetric_distributionstringYesWhether joint involvement is symmetric
morning_stiffness_durationstringYesDuration of morning stiffness
tender_joints_countintegerYesNumber of tender joints (out of 68 assessed joints)(joints)
swollen_joints_countintegerYesNumber of swollen joints (out of 66 assessed joints)(joints)
c_reactive_proteinfloatYesC-reactive protein level(mg/L)
rheumatoid_factorstringYesPresence of rheumatoid factor
anti_ccp_antibodiesstringYesPresence of anti-cyclic citrullinated peptide (anti-CCP) antibodies

Score Interpretation & Guidance

RangeStageDescription
0–6Low RiskLow risk of progression to rheumatoid arthritis
6.01–7.99Indeterminate RiskIndeterminate risk of progression to rheumatoid arthritis
8–20High RiskHigh risk of progression to rheumatoid arthritis

Evidence-Based References (EBM)

  • van der Helm-van Mil AHM, le Cessie S, van Dongen H, Breedveld FC, Toes REM, Huizinga TWJ. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum. 2007 Feb;56(2):433-40.
  • Kuriya B, Cheng CK, Chen HM, Bykerk VP. Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis. Ann Rheum Dis. 2009 Sep;68(9):1482-5.
  • Tamai M, Kawakami A, Uetani M, Fukushima A, Arima K, Iwanaga N, et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum. 2009 Oct 15;61(10):1324-31.

Related calculators